Abstract:BACKGROUND&AIMS: Transient receptor potential vanilloid 4 (TRPV4) is a nonselective cation channel, and involved in physical sensing in various types of tissues. TRPV4 is expressed in sensory neuron and vascular endothelial cells in various organs. In gastrointestinal tracts, TRPV4 activation in epithelial cells increases in intracellular calcium concentrations and induces colitis. However, the localization and the role of the TRPV4 channel expressed in vascular endothelial cells in colitis are still poorly defined. In the present study, we investigated the alteration of TRPV4 expression in the colonic vascular endothelial cells during dextran sulfate sodium (DSS)-induced colitis. METHODS: Eight week-old wild type (WT) and TRPV4 knock-out (TRPV4 KO) mice were used. Colitis was induced by 2% DSS solution given as drinking water for 7 days. The disease activity index (DAI) was evaluated during the treatment, while colon length, histological damage, and myeloperoxidase (MPO) activity were examined post-DSS treatment. Immunohistochemical analysis was performed in distal colon. TRPV4-immunoreactivity was detected by using immunohistochemical staining with fluorescein-conjugated tyramide amplification. CD31, CD105, CD11b, CD68, Ly6B.2, and VEGF receptor-2 were detected by indirect staining with their specific antibodies. Vascular leakage was investigated using Evans blue dye extrusion assay. RESULTS: TRPV4 KO mice protected against DSS-induced weight loss, neutrophil (MPO), colon shortening, diarrhea, occult-fecal blood, and histological damage. TRPV4 immunoreactivities were detected mostly in epithelial cells of normal distal colon. DSS treatment drastically increased TRPV4 expression in vascular endothelial cells of mucosa and submucosal layer which colocalized with CD31, CD105, and VEGF receptor-2, but not epithelial cells. Repeated intrarectal and intravenous administration of TRPV4 agonist GSK1016790A exacerbated the severity of DSS colitis. Increased vascular permeability was observed following single intravenous administration of GSK1016790A in DSS colitis and this effect was abolished with TRPV4 antagonist RN1734. CD11b, CD68, Ly6B.2 immunopositive cells were detected around TRPV4 positive vascular endothelial cells in mucosa and submucosal layer in DSS colitis. CONCLUSION: These findings indicate that the alteration of TRPV4 in vascular endothelial cells may contribute to progression of colonic inflammation via increasing vascular permeability.

Gain of Function of Ion Channel TRPV1 Exacerbates Experimental Colitis by Promoting Dendritic Cell Activation.

The ion channel TRPV1 gain-of-function reprograms the immune microenvironment to facilitate colorectal tumorigenesis

Upregulation of the Transient Receptor Potential Vanilloid 1 in Colonic Epithelium of Patients with Active Inflammatory Bowel Disease.

TRPV2 in the Development of Experimental Colitis

The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1

Mo1693 Activation of Bone Marrow-Derived TRPV4-Expressing M2 Macrophages Promotes Intestinal Contraction

TLR4 Mediates Upregulation and Sensitization of TRPV1 in Primary Afferent Neurons in 2,4,6-Trinitrobenzene Sulfate-Induced Colitis

Transient Receptor Potential Channels and Inflammatory Bowel Disease

Transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 contribute to the progression of colonic inflammation in dextran sulfate sodium-induced colitis in mice: Links to calcitonin gene-related peptide and substance P

Tripartite Motif-Containing (TRIM) 21 Negatively Regulates Intestinal Mucosal Inflammation Through Inhibiting TH1/TH17 Cell Differentiation in Patients with Inflammatory Bowel Diseases.

Transient Receptor Potential Ankyrin-1 Participates in Visceral Hyperalgesia Following Experimental Colitis

[Physiological and pathophysiological roles of TRPV4 channel in gastrointestinal tract]

Potential Role of Th17 Cells in the Pathogenesis of Inflammatory Bowel Disease.

The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons

Data from Vanilloid Receptor-1 Regulates Neurogenic Inflammation in Colon and Protects Mice from Colon Cancer

TRP channels in inflammatory bowel disease: Potential therapeutic targets

Dectin-1 induces TRPV1 sensitization and contributes to visceral hypersensitivity of irritable bowel syndrome in male mice

Expression and function of transient receptor potential melastatin 3 in the spinal afferent innervation of the mouse colon

703 Aberrant Antigen Presenting Cells Activate Effector T Cells and Inhibit Regulatory T Cell Function

TL1A primed dendritic cells activation exacerbated chronic murine colitis

Pharmacological Activation of TRPC6 Channel Prevents Colitis Progression